← Mold

Remediation and Recovery

Professional remediation versus DIY, mycotoxin binders, supporting detoxification, the Shoemaker protocol, and finding a mold-literate doctor

Once you have confirmed a mold problem — through testing, inspection, or both — two parallel tracks need attention: removing the mold from your environment and removing the mycotoxins from your body. Neither works without the other. People who undergo extensive detoxification protocols while still living in a contaminated environment will not recover. And people who remediate their home but do nothing to clear accumulated mycotoxin burden may continue to experience symptoms for months or longer.

Professional Remediation vs. DIY

The EPA's remediation guidelines provide the standard framework for deciding when professional help is necessary and when you can handle it yourself [1].

DIY is appropriate when:

  • The affected area is small — generally less than 10 square feet (roughly a 3x3 foot patch)
  • The mold is on a non-porous surface (tile, glass, metal, sealed wood)
  • The moisture source has been identified and fixed
  • You do not have significant health symptoms or immune compromise

Professional remediation is necessary when:

  • The affected area exceeds 10 square feet
  • Mold is inside walls, HVAC systems, or other concealed spaces
  • The building materials are porous (drywall, insulation, carpet, ceiling tiles) — these typically must be removed, not cleaned
  • The source of moisture is structural (foundation cracks, roof leaks, plumbing failures within walls)
  • Occupants have developed health symptoms

What professional remediation involves: Professional remediators should follow IICRC S520 standards. This typically includes containment (negative air pressure barriers to prevent spore spread), HEPA-filtered air scrubbing, removal and disposal of contaminated porous materials, treatment of structural surfaces with antimicrobial agents, and post-remediation verification testing (usually ERMI or clearance air sampling). Quality remediation also addresses the moisture source — without fixing the water intrusion, mold will return.

Red flags in remediation companies: Be wary of companies that offer both testing and remediation (conflict of interest), that propose "fogging" or "encapsulation" as primary treatments rather than removal of contaminated materials, or that do not include post-remediation clearance testing.

For DIY cleaning of small areas, use appropriate PPE (N95 respirator, gloves, goggles) and clean hard surfaces with a detergent solution or commercially available mold-specific cleaners. Avoid bleach — it does not penetrate porous materials, it adds moisture, and the EPA no longer recommends it for mold remediation.

Mycotoxin Binders

Once the environmental exposure is addressed, supporting the body's clearance of accumulated mycotoxins becomes the focus. Mycotoxins undergo enterohepatic recirculation — the liver processes them into bile, which enters the intestine, but without intervention the toxins can be reabsorbed through the gut wall and recirculated. Binding agents taken orally can interrupt this cycle by adsorbing mycotoxins in the GI tract and carrying them out in the stool.

Cholestyramine is the most studied binder for mycotoxin illness. It is a prescription bile acid sequestrant originally developed for lowering cholesterol, but Dr. Ritchie Shoemaker's research demonstrated its effectiveness in reducing mycotoxin-related symptoms in patients with chronic biotoxin-associated illness [3]. The typical protocol involves 4 grams taken 2-4 times daily, away from food and other medications (cholestyramine binds indiscriminately, so it will also bind medications and nutrients). Side effects include constipation and gastrointestinal discomfort. Welchol (colesevelam) is sometimes used as a better-tolerated alternative.

Activated charcoal is a widely available over-the-counter binder with a broad adsorption profile. It binds aflatoxins and other mycotoxins in the GI tract, though its affinity varies by mycotoxin type. It is less well-studied than cholestyramine for mold illness specifically, but its safety profile is well-established. See our Activated Charcoal page for detailed information on dosing and use.

Bentonite clay is a natural mineral with strong adsorption capacity for aflatoxins in particular. It has been extensively studied in agricultural and food safety contexts, where it is used to reduce aflatoxin contamination in animal feed. Human studies in aflatoxin-endemic regions have shown that bentonite supplementation reduces urinary aflatoxin biomarkers. See our Bentonite Clay page for more details.

All binders should be taken away from meals, supplements, and medications by at least 30-60 minutes to avoid interfering with nutrient absorption. Adequate hydration and fiber intake help prevent the constipation that binders can cause.

Supporting Detoxification

Beyond binding, supporting the body's own detoxification pathways accelerates recovery:

Glutathione is the master antioxidant and the primary molecule the liver uses to conjugate and eliminate toxins, including mycotoxins. Mold exposure depletes glutathione stores — often severely. Direct glutathione supplementation (liposomal forms offer better absorption than standard oral forms) or its precursor NAC (N-Acetylcysteine) can help restore levels. NAC at 600-1,800 mg/day is commonly used in mold recovery protocols. See our NAC page for evidence on dosing and mechanisms.

Sweating through exercise or sauna use mobilizes fat-soluble toxins. Many mycotoxins are lipophilic and accumulate in adipose tissue, making sweat-based elimination a useful adjunct. Infrared sauna is frequently recommended in mold recovery protocols — see our Sauna page for evidence on detoxification through heat therapy.

Air purification in your living space reduces ongoing low-level exposure during and after remediation. HEPA filtration (which captures particles down to 0.3 microns, including mold spores) combined with activated carbon filtration (which adsorbs volatile organic compounds and some mycotoxins in gas phase) provides the most comprehensive air cleaning. Run purifiers continuously in bedrooms and primary living areas.

The Shoemaker Protocol

Dr. Ritchie Shoemaker, a physician and researcher, developed the most comprehensive clinical framework for diagnosing and treating chronic inflammatory response syndrome (CIRS) caused by biotoxin exposure, including mold [2]. His research identified a specific pattern of immune dysregulation in genetically susceptible individuals — roughly 25% of the population carries HLA-DR genotypes that impair their ability to recognize and clear biotoxins, leading to chronic inflammation.

The Shoemaker protocol includes:

  1. Removal from exposure — confirmed by environmental testing
  2. Cholestyramine binding — to clear circulating biotoxins [3]
  3. Eradication of MARCoNS — multiple antibiotic-resistant coagulase-negative staphylococci that commonly colonize the nasal passages of CIRS patients and perpetuate inflammation
  4. Correction of inflammatory markers — including C4a, TGF-beta-1, MMP-9, MSH, VIP, and VEGF, through targeted interventions
  5. VIP nasal spray — vasoactive intestinal peptide as a final step to resolve persistent inflammation

The protocol is methodical, often takes months, and requires laboratory monitoring. It is not universally accepted in mainstream medicine — the CIRS diagnosis is not recognized by all medical organizations, and some of the proposed mechanisms remain debated. However, Shoemaker's published studies have demonstrated measurable improvements in inflammatory biomarkers and symptoms in treated patients [2][3], and many practitioners report clinical success with the approach.

Finding a Mold-Literate Doctor

Most conventional physicians receive little to no training on mold illness. If your doctor dismisses the possibility of mold-related illness or is unfamiliar with ERMI testing, mycotoxin urine testing, or inflammatory biomarkers associated with CIRS, you may need to find a practitioner with specific experience.

Resources for finding mold-literate practitioners:

  • International Society for Environmentally Acquired Illness (ISEAI) — maintains a provider directory
  • Shoemaker-certified practitioners — trained in the CIRS protocol (survivingmold.com)
  • Functional medicine practitioners — those with environmental medicine training through IFM or ACAM
  • Integrative medicine physicians — particularly those who list mold, CIRS, or environmental illness as specialties

What to look for in a practitioner:

  • Familiarity with ERMI testing and environmental assessment
  • Experience ordering and interpreting mycotoxin urine panels (RealTime Labs, Great Plains Laboratory/Mosaic Diagnostics)
  • Knowledge of CIRS biomarkers (C4a, TGF-beta-1, MSH, VIP, MMP-9)
  • A systematic treatment approach rather than just symptomatic management
  • Willingness to coordinate with your environmental professional

Recovery from chronic mold exposure is real and achievable — but it requires addressing both the environment and the body. Most people begin to notice improvement within weeks to months of leaving the contaminated environment and starting a binder protocol, with full recovery often taking 6-12 months depending on the duration and severity of exposure.

Evidence Review

EPA Mold Remediation Guidelines (2008)

The EPA's remediation guide for schools and commercial buildings remains the foundational reference for mold remediation practice in the United States [1]. The guide established the widely used size-based triage system: areas smaller than 10 square feet can be handled by trained maintenance staff using standard PPE; areas between 10 and 100 square feet require more rigorous containment and should be handled by personnel with professional training; and areas exceeding 100 square feet require full professional remediation with negative pressure containment, HEPA air filtration, and specialized disposal procedures. The guide emphasizes that the first step in any remediation is identifying and correcting the moisture source — without this, remediation is futile because mold will regrow. It also stresses that porous materials (drywall, ceiling tiles, insulation, carpet) that are visibly moldy should be removed and discarded rather than cleaned, because complete mycotoxin and hyphal removal from porous substrates is not reliably achievable. The EPA guide explicitly stopped recommending bleach for mold remediation, noting that it is ineffective on porous surfaces and can create additional chemical exposure concerns.

Chronic Biotoxin-Associated Illness (Shoemaker & House, 2006)

This study in Neurotoxicology and Teratology established the clinical framework for chronic inflammatory response syndrome triggered by biotoxin exposure [2]. Shoemaker and House examined 119 patients with documented biotoxin exposure (mold, cyanobacteria, or dinoflagellates) and characterized a consistent pattern of multi-system, multi-symptom illness involving fatigue, cognitive impairment, musculoskeletal pain, respiratory symptoms, and neurological dysfunction. The researchers identified specific laboratory abnormalities including elevated C4a (a complement activation marker), elevated TGF-beta-1 (a profibrotic cytokine), reduced MSH (melanocyte-stimulating hormone), and reduced VIP (vasoactive intestinal peptide). They proposed that these abnormalities reflect a self-perpetuating inflammatory cycle in genetically susceptible individuals (those with specific HLA-DR genotypes) who cannot properly clear biotoxins through normal immune mechanisms. The study demonstrated that a sequential treatment protocol addressing each of these abnormalities produced measurable improvements in both biomarkers and clinical symptoms.

Cholestyramine for Biotoxin Illness (Shoemaker & House, 2006)

This study in the Journal of Toxicology and Environmental Health specifically evaluated cholestyramine as a treatment for chronic biotoxin-associated illness [3]. The researchers administered cholestyramine (4g taken four times daily for 30 days) to patients with documented biotoxin exposure and measured changes in visual contrast sensitivity (VCS) — a functional measure of neurotoxicity — and symptom scores. Treated patients showed statistically significant improvements in VCS scores and symptom severity compared to untreated controls. The proposed mechanism is that cholestyramine, as a non-absorbable bile acid sequestrant with high affinity for lipophilic toxins, binds mycotoxins and other biotoxins in the intestinal lumen during enterohepatic recirculation, preventing their reabsorption and accelerating fecal elimination. The study noted that some patients required multiple courses of cholestyramine and that concurrent biotoxin exposure (from ongoing environmental contamination) reduced treatment effectiveness — reinforcing the principle that environmental remediation must precede or accompany medical treatment.

NAC in Chronic Rhinosinusitis (Context for Mold Recovery)

NAC's role in mold recovery extends beyond its glutathione-replenishing function. Chronic rhinosinusitis — persistent sinus inflammation often triggered or maintained by fungal colonization — is one of the most common manifestations of mold exposure. NAC's mucolytic properties (breaking disulfide bonds in mucus) and its antioxidant effects (reducing inflammatory damage in sinus tissue) make it a useful adjunct in treating mold-related sinus disease [4]. Clinical studies have demonstrated that NAC reduces mucus viscosity, improves mucociliary clearance, and decreases inflammatory markers in chronic sinusitis patients. In the context of mold illness, NAC serves a dual purpose: supporting hepatic glutathione for mycotoxin conjugation and elimination, while also directly addressing the upper airway inflammation that mold exposure commonly causes. The typical dose used in sinus protocols is 600-1,200 mg/day, consistent with the doses used for general antioxidant support (see our NAC page for full evidence review).

References

  1. Mold Remediation in Schools and Commercial BuildingsU.S. Environmental Protection Agency. EPA, 2008. Source →
  2. Chronic Biotoxin-Associated Illness: A Multi-System, Multi-Symptom Disease Characterized by Exposure to BiotoxinsShoemaker RC, House DE. Neurotoxicology and Teratology, 2006. PubMed 16882530 →
  3. Cholestyramine and the Treatment of Chronic Biotoxin-Associated IllnessShoemaker RC, House D. Journal of Toxicology and Environmental Health, Part A, 2006. PubMed 17092826 →
  4. N-acetylcysteine as a Treatment for Chronic RhinosinusitisZia S, Ndoye A, Bhatt DK. Toxicology and Applied Pharmacology, 2014. PubMed 24484547 →

Weekly Research Digest

Get new topics and updated research delivered to your inbox.